Processa Pharmaceuticals, Inc.
PCSA· Nasdaq
PCSAProcessa Pharmaceuticals, Inc.
Filed May 14, 2014 · 10-Q · 44 days after period end · 0001393905-14-000288
| Metric | Q1 2014 | Q1 2013 |
|---|---|---|
| Revenue | $20.44K | $19.20K |
| Net Income | -$1.34M | -$816.37K |
| EPS Diluted | -$0.17 | -$0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Processa Pharmaceuticals, Inc. · CIK 1533743 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 14, 2014 · 44 d after period end
